Cited by 57Clostridium difficile and Clostridium perfringens researchBlood Coagulation and Thrombosis MechanismsGastrointestinal motility and disorders

Protease-Activated Receptor 2, Dipeptidyl Peptidase I, and Proteases Mediate Clostridium difficile Toxin A Enteritis

Open access
Cottrell, Graeme S., Amadesi, Silvia, Pikios, Stella, Camerer, Eric, Willardsen, J. Adam, Murphy, Brett R., Caughey, George H., Wolters, Paul J. +6 more·2007·Gastroenterology

Abstract

Background & aims We studied the role of protease-activated receptor 2 (PAR(2)) and its activating enzymes, trypsins and tryptase, in Clostridium difficile toxin A (TxA)-induced enteritis.Methods We injected TxA into ileal loops in PAR(2) or dipeptidyl peptidase I (DPPI) knockout mice or in wild-type mice pretreated with tryptase inhibitors (FUT-175 or MPI-0442352) or soybean trypsin inhibitor. We examined the effect of TxA on expression and activity of PAR(2) and trypsin IV messenger RNA in the ileum and cultured colonocytes. We injected activating peptide (AP), trypsins, tryptase, and p23 in wild-type mice, some pretreated with the neurokinin 1 receptor antagonist SR140333.Results TxA increased fluid secretion, myeloperoxidase activity in fluid and tissue, and histologic damage. PAR(2) deletion decreased TxA-induced ileitis, reduced luminal fluid secretion by 20%, decreased tissue and fluid myeloperoxidase by 50%, and diminished epithelial damage, edema, and neutrophil infiltration. DPPI deletion reduced secretion by 20% and fluid myeloperoxidase by 55%. In wild-type mice, FUT-175 or MPI-0442352 inhibited secretion by 24%-28% and tissue and fluid myeloperoxidase by 31%-71%. Soybean trypsin inhibitor reduced secretion to background levels and tissue myeloperoxidase by up to 50%. TxA increased expression of PAR(2) and trypsin IV in enterocytes and colonocytes and caused a 2-fold increase in Ca(2+) responses to PAR(2) AP. AP, tryptase, and trypsin isozymes (trypsin I/II, trypsin IV, p23) caused ileitis. SR140333 prevented AP-induced ileitis.Conclusions PAR(2) and its activators are proinflammatory in TxA-induced enteritis. TxA stimulates existing PAR(2) and up-regulates PAR(2) and activating proteases, and PAR(2) causes inflammation by neurogenic mechanisms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2007.03.101

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mucosal damage and inflammation caused by toxin A from C. difficile is markedly reduced when PAR-2 activation is prevented.

    “Mucosal damage and inflammation caused by toxin A from the enteric pathogen C. difficile is markedly reduced when PAR-2 activation is prevented.135”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

2 of the 59 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Cottrell, G. S., Amadesi, S., Pikios, S., Camerer, E., Willardsen, J. A., Murphy, B. R., Caughey, G. H., Wolters, P. J., Coughlin, S. R., Peterson, A., Knecht, W., Pothoulakis, C., Bunnett, N. W., & Grady, E. F.
Affiliations
  • University of California, San Francisco (US)
  • AstraZeneca (Sweden) (SE)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
Grady, Eileen F.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2007-06
Volume
132
Issue
7
Pages
2422-2437
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2058871622
Cited by
56
References
59
Citations by year
2026: 1 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 1 · 2016: 2 · 2014: 2 · 2013: 5 · 2012: 4
FWCI
3.80
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute
  • Crohn's and Colitis Foundation of America (DK57840, DK52388, DK47343, DK39957, HL024136, DK43207, DK41301, 1730)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
protease-activated receptor 2, dipeptidyl peptidase I, Clostridium difficile toxin A, tryptase, p23, tryptase inhibitors, neurokinin-1 receptor, SR140333, ileitis, intestinal secretion, myeloperoxidase, neutrophil infiltration, neurogenic inflammation
MeSH terms
Animals, Bacterial Toxins, Cells, Cultured, Colon, Enteritis, Enterotoxins, Granulocytes, Ileitis, Ileum, Intestinal Mucosa, Intestines, Peroxidase, Nervous System, Peptide Hydrolases, Trypsin, Trypsin Inhibitors, Up-Regulation, Receptors, Neurokinin-1, Mice, Knockout, Cathepsin C, Receptor, PAR-2, Mice, Tryptases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review